Avadel Pharmaceuticals PLC (AVDL)
18.09
+0.79
(+4.57%)
USD |
NASDAQ |
Apr 23, 16:00
Avadel Pharmaceuticals Net Income (Quarterly): -28.79M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.79M |
| September 30, 2023 | -36.27M |
| June 30, 2023 | -64.43M |
| March 31, 2023 | -30.78M |
| December 31, 2022 | -27.45M |
| September 30, 2022 | -20.15M |
| June 30, 2022 | -63.44M |
| March 31, 2022 | -26.42M |
| December 31, 2021 | -22.30M |
| September 30, 2021 | -22.00M |
| June 30, 2021 | -19.58M |
| March 31, 2021 | -13.44M |
| December 31, 2020 | -11.28M |
| September 30, 2020 | -11.70M |
| June 30, 2020 | 30.87M |
| March 31, 2020 | -0.865M |
| December 31, 2019 | -2.739M |
| September 30, 2019 | -8.864M |
| June 30, 2019 | -8.605M |
| March 31, 2019 | -13.02M |
| December 31, 2018 | -63.86M |
| September 30, 2018 | -15.77M |
| June 30, 2018 | -3.438M |
| March 31, 2018 | -12.24M |
| December 31, 2017 | -8.245M |
| Date | Value |
|---|---|
| September 30, 2017 | 21.68M |
| June 30, 2017 | 28.93M |
| March 31, 2017 | 25.91M |
| December 31, 2016 | 4.734M |
| September 30, 2016 | -19.99M |
| June 30, 2016 | -19.96M |
| March 31, 2016 | -6.058M |
| December 31, 2015 | 73.52M |
| September 30, 2015 | -28.08M |
| June 30, 2015 | -16.86M |
| March 31, 2015 | 11.65M |
| December 31, 2014 | -27.71M |
| September 30, 2014 | -10.05M |
| June 30, 2014 | -21.07M |
| March 31, 2014 | -26.64M |
| December 31, 2013 | 5.127M |
| September 30, 2013 | -6.369M |
| June 30, 2013 | -32.85M |
| March 31, 2013 | -8.829M |
| December 31, 2012 | 9.102M |
| September 30, 2012 | -6.425M |
| June 30, 2012 | -5.917M |
| March 31, 2012 | 0.012M |
| December 31, 2011 | -2.091M |
| September 30, 2011 | 1.703M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-64.43M
Minimum
Jun 2023
30.87M
Maximum
Jun 2020
-20.43M
Average
-20.15M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| Trinity Biotech PLC | -6.721M |
| Medtronic PLC | 1.322B |
| Biophytis SA | -- |
| Jazz Pharmaceuticals PLC | 94.15M |
| DBV Technologies SA | -11.19M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 19.45M |
| Total Expenses (Quarterly) | 44.35M |
| EPS Diluted (Quarterly) | -0.29 |
| Enterprise Value | 1.533B |
| Gross Profit Margin (Quarterly) | 96.44% |
| Profit Margin (Quarterly) | -148.0% |
| Earnings Yield | -11.11% |
| Normalized Earnings Yield | -10.36 |